Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OptiTrain - Optimal Training for Women With Breast Cancer During Chemotherapy Treatment

NCT02522260 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02522260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02522260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OptiTrain - Optimal Training for Women With Breast Cancer During Chemotherapy Treatment
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2013
Completion date
June 30, 2021
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

well being